Marketing-authorisation holder · United States
Ph Health
55 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 55
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADRENALIN1mg base/ml (eq 1mg base/ml) | 30mg base/30ml (eq 1mg base/ml) · Solution | Epinephrine | United States | Marketed | 2012 |
| ADRENALIN10mg/250ml (40mcg/ml) | 2mg/250ml (8mcg/ml) | 4mg/250ml (16mcg/ml) | 5mg/250ml (20mcg/ml) | 8mg/250ml (32mcg/ml) · Solution | Epinephrine | United States | Marketed | 2023 |
| ALISKIREN HEMIFUMARATE150mg base | 300mg base · Tablet | Aliskiren hemifumarate | United States | Marketed | 2019 |
| ALVIMOPAN12mg · Capsule | Alvimopan | United States | Marketed | 2019 |
| BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE140mg; 125mg; 125mg · Capsule | Bismuth subcitrate, Metronidazole, Tetracycline | United States | Marketed | 2023 |
| BREVITAL SODIUM2.5gm/vial | 200mg/vial | 500mg/vial | 5gm/vial · Injectable | Methohexital | United States | Marketed | 1960 |
| BUPRENORPHINE HYDROCHLORIDE0.3mg base/ml · Injectable | Buprenorphine | United States | Marketed | 1996 |
| CALOMIST25mcg/spray · Spray, metered | Vitamin b12 | United States | Not marketed | 2007 |
| CHOLESTYRAMINE LIGHT4gm resin/packet | 4gm resin/scoopful · Powder | Colestyramine | United States | Marketed | 1996 |
| COLY-MYCIN M150mg base/vial · Injectable | Colistin | United States | Not marketed | 1970 |
| COLY-MYCIN S3mg base/ml; 10mg/ml; 3.3mg base/ml; 0.5mg/ml · Suspension/drops | Colistin, Hydrocortisone, Neomycin, Thonzonium | United States | Marketed | 1962 |
| CORPHEDRA50mg/ml (50mg/ml) · Solution | Ephedrine | United States | Marketed | 2017 |
| CYCLAFEM 0.5/350.035mg; 0.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2015 |
| CYCLAFEM 1/350.035mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2010 |
| CYCLAFEM 7/7/70.035mg,0.035mg,0.035mg; 0.5mg,0.75mg,1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2010 |
| DANTRIUM100mg | 25mg | 50mg · Capsule | Dantrolene | United States | Marketed | 1974 |
| DANTRIUM20mg/vial · Injectable | Dantrolene | United States | Marketed | 1979 |
| DELESTROGEN10MG/ML | 20MG/ML | 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Estradiol | United States | Marketed | 1954 |
| EMOQUETTE0.15mg; 0.03mg · Tablet | Desogestrel, Ethinyl estradiol | United States | Not marketed | 2011 |
| FLUOXETINE HYDROCHLORIDE10mg base | 20mg base | 40mg base | 60mg base · Tablet | Fluoxetine | United States | Marketed | 2001 |
| GANCICLOVIR SODIUM500mg base/vial · Injectable | Ganciclovir | United States | Marketed | 2003 |
| GILDAGIA0.035mg; 0.4mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2012 |
| GILDESS 1/200.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2005 |
| GILDESS 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2005 |
| GILDESS 24 FE0.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2014 |